U.S. patent number D842,453 [Application Number D/618,661] was granted by the patent office on 2019-03-05 for pharmaceutical tablet.
This patent grant is currently assigned to Laboratoire HRA-PHARMA. The grantee listed for this patent is LABORATOIRE HRA-PHARMA. Invention is credited to Stephanie Pradet, Christine Seguin, Suzanne Tran, Frederique Welgryn.
![](/patent/grant/D0842453/USD0842453-20190305-D00000.png)
![](/patent/grant/D0842453/USD0842453-20190305-D00001.png)
![](/patent/grant/D0842453/USD0842453-20190305-D00002.png)
![](/patent/grant/D0842453/USD0842453-20190305-D00003.png)
![](/patent/grant/D0842453/USD0842453-20190305-D00004.png)
![](/patent/grant/D0842453/USD0842453-20190305-D00005.png)
![](/patent/grant/D0842453/USD0842453-20190305-D00006.png)
![](/patent/grant/D0842453/USD0842453-20190305-D00007.png)
United States Patent |
D842,453 |
Pradet , et al. |
March 5, 2019 |
Pharmaceutical tablet
Claims
CLAIM The ornamental design for a pharmaceutical tablet, as shown
and described.
Inventors: |
Pradet; Stephanie (la Garenne
Colombes, FR), Welgryn; Frederique (Paris,
FR), Tran; Suzanne (Maisons-Alfort, FR),
Seguin; Christine (Paris, FR) |
Applicant: |
Name |
City |
State |
Country |
Type |
LABORATOIRE HRA-PHARMA |
Paris |
N/A |
FR |
|
|
Assignee: |
Laboratoire HRA-PHARMA (Paris,
FR)
|
Appl.
No.: |
D/618,661 |
Filed: |
September 22, 2017 |
Foreign Application Priority Data
|
|
|
|
|
Sep 22, 2017 [EP] |
|
|
004366938 |
|
Current U.S.
Class: |
D24/101 |
Current International
Class: |
2401 |
Field of
Search: |
;D24/100-104 |
References Cited
[Referenced By]
U.S. Patent Documents
Primary Examiner: Hanson; Charles D
Attorney, Agent or Firm: Leason Ellis LLP
Description
FIG. 1 is a perspective view of the pharmaceutical tablet according
to an embodiment of the present invention as viewed from the bottom
and to the right of the tablet;
FIG. 2 is a perspective view of the pharmaceutical tablet as viewed
from the top and to the left of the tablet;
FIG. 3 is a front plan view of the pharmaceutical tablet which
includes broken line markings for a cross-sectional plane axis
9-9;
FIG. 4 is a rear plan view of the pharmaceutical tablet;
FIG. 5 is a left side view of the pharmaceutical tablet;
FIG. 6 is a right side view of the pharmaceutical tablet b
FIG. 7 is a bottom view of the pharmaceutical tablet;
FIG. 8 is a top of the pharmaceutical tablet; and,
FIG. 9 is a cross-sectional view of the pharmaceutical tablet taken
along axis 9-9 in FIG. 3.
The broken line marked 9-9 in FIG. 3 refers to a cross-sectional
plane for FIG. 9 and forms no part of the claimed invention.
* * * * *